Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
3.19M
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-193K
-
Total reported value, excl. options
-
$0
-
Value change
-
-$385K
-
Number of sells
-
-7
Significant Holders of AVENUE THERAPEUTICS, INC. - Common Stock, $0.0001 Par Value (ATXI) as of Q1 2025
7 filings reported holding ATXI - AVENUE THERAPEUTICS, INC. - Common Stock, $0.0001 Par Value as of Q1 2025.
AVENUE THERAPEUTICS, INC. - Common Stock, $0.0001 Par Value (ATXI) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
of 3.19M outstanding shares and own 0% of the company stock.
Largest 7 shareholders include SBI Securities Co., Ltd. (0 shares), WELLS FARGO & COMPANY/MN (0 shares), UBS Group AG (0 shares), Tower Research Capital LLC (TRC) (0 shares), BOOTHBAY FUND MANAGEMENT, LLC (0 shares), BANK OF AMERICA CORP /DE/ (0 shares), and Ikarian Capital, LLC (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.